` Comparison: 323990 vs ABBV - Alpha Spread
Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

V
323990
vs
ABBV

Over the past 12 months, Vaxcell Bio Therapeutics has underperformed ABBV, delivering a return of -2% compared to the ABBV's +15% growth.

Valuation Growth Profitability Solvency Stocks Performance
Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
323990
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
323990 ABBV
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

V
Intrinsic Value
3 717.7 KRW
Overvaluation 60%
Intrinsic Value
Price
ABBV Intrinsic Value
219.81 USD
Overvaluation 3%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
V
Vaxcell Bio Therapeutics
KOSDAQ:323990
9 360 KRW
Abbvie Inc
NYSE:ABBV
226.93 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
323990, ABBV

323990
ABBV
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
V
Vaxcell Bio Therapeutics
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
323990, ABBV

323990
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
V
Vaxcell Bio Therapeutics
KOSDAQ:323990
Abbvie Inc
NYSE:ABBV
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Vaxcell Bio Therapeutics
15.6%
ABBV
71.2%
LTM 3Y Avg 5Y Avg 10Y Avg
V
Vaxcell Bio Therapeutics
Abbvie Inc

Operating Margin

Vaxcell Bio Therapeutics
-241.1%
ABBV
33.1%
LTM 3Y Avg 5Y Avg 10Y Avg
V
Vaxcell Bio Therapeutics
Abbvie Inc

Net Margin

Vaxcell Bio Therapeutics
-185.1%
ABBV
3.9%
LTM 3Y Avg 5Y Avg 10Y Avg
V
Vaxcell Bio Therapeutics
Abbvie Inc

FCF Margin

Vaxcell Bio Therapeutics
-257.3%
ABBV
33%
LTM 3Y Avg 5Y Avg 10Y Avg
V
Vaxcell Bio Therapeutics
Abbvie Inc

ROE

Vaxcell Bio Therapeutics
-17.7%
ABBV
138.5%
LTM 3Y Avg 5Y Avg 10Y Avg
V
Vaxcell Bio Therapeutics
Abbvie Inc

ROA

Vaxcell Bio Therapeutics
-16.5%
ABBV
1.7%
LTM 3Y Avg 5Y Avg 10Y Avg
V
Vaxcell Bio Therapeutics
Abbvie Inc

ROIC

Vaxcell Bio Therapeutics
-38.2%
ABBV
28.4%
LTM 3Y Avg 5Y Avg 10Y Avg
V
Vaxcell Bio Therapeutics
Abbvie Inc

ROCE

Vaxcell Bio Therapeutics
-22.3%
ABBV
20.2%
LTM 3Y Avg 5Y Avg 10Y Avg
V
Vaxcell Bio Therapeutics
Abbvie Inc

Solvency Comparison

V
Vaxcell Bio Therapeutics
Equity Waterfall
Assets
Liabilities
Equity
What is Equity Waterfall?
Abbvie Inc
Equity Waterfall
Assets
Liabilities
Equity
What is Equity Waterfall?
No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
323990, ABBV

Loading
323990
ABBV
Add Stock
www.alphaspread.com
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
323990, ABBV

Loading
323990
ABBV
Difference
www.alphaspread.com
1Y 3Y 5Y 10Y 15Y 20Y

Performance By Year
323990, ABBV

Loading
323990
ABBV
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 323990 to other stocks
PNEXF
Pharnext SCA
AMGN
Amgen Inc
GILD
Gilead Sciences Inc
VRTX
Vertex Pharmaceuticals I...
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account
ALPHA SPREAD
Follow us
Join more than 318,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.